Secondary Ph-positive CML with a minority monosomy 7 clone

Area of Science:

• Hematology
• Oncology
• Genetics

Background:

• This study examines a rare case of secondary cancer development.
• Focuses on the emergence of chronic myelogenous leukemia (CML) following treatment for lymphoblastic lymphoma.

Observation:

• A patient with lymphoblastic lymphoma, initially showing normal cytogenetics, developed CML 16 months post-treatment.
• Diagnostic findings included a Philadelphia chromosome (Ph) and t(9;22) translocation, with a minor clone exhibiting 45,XY,-7.
• The patient's CML progressed rapidly to blast crisis, leading to death within three months.

Findings:

• Cytogenetic and molecular analyses confirmed the presence of the Philadelphia chromosome (Ph) and bcr rearrangement in the CML cells.
• Evidence suggests a clonal relationship between the lymphoma treatment and the subsequent development of CML.
• The study identified a distinct genetic alteration, t(9;22)(q34;q11), characteristic of CML.

Implications:

• This case underscores the importance of long-term monitoring for secondary malignancies in cancer survivors.
• Highlights the potential for therapy-induced leukemogenesis, particularly CML, after lymphoma treatment.
• Suggests further research into the mechanisms underlying treatment-related secondary cancers is warranted.